X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (26) 26
humans (16) 16
index medicus (16) 16
middle aged (11) 11
cancer (10) 10
male (10) 10
chemotherapy (9) 9
female (9) 9
quality of life (9) 9
survival (9) 9
adult (8) 8
aged (7) 7
metastasis (7) 7
combined modality therapy (6) 6
disease-free survival (6) 6
prognosis (6) 6
radiotherapy (6) 6
research (6) 6
hematology, oncology and palliative medicine (5) 5
oncology, experimental (5) 5
surgery (5) 5
treatment outcome (5) 5
adenocarcinoma (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
cancer patients (4) 4
care and treatment (4) 4
chemotherapy, adjuvant (4) 4
colorectal neoplasms - pathology (4) 4
european-organization (4) 4
gastric cancer (4) 4
kaplan-meier estimate (4) 4
liver neoplasms - secondary (4) 4
metastases (4) 4
oxaliplatin (4) 4
stomach cancer (4) 4
survival analysis (4) 4
adjuvant chemotherapy (3) 3
breast-cancer (3) 3
carcinoma (3) 3
colorectal cancer (3) 3
eortc (3) 3
fluorouracil (3) 3
fluorouracil - administration & dosage (3) 3
gastrointestinal system (3) 3
health status (3) 3
hepatic resection (3) 3
immunohistochemistry (3) 3
irinotecan (3) 3
leucovorin - administration & dosage (3) 3
liver neoplasms - drug therapy (3) 3
liver neoplasms - surgery (3) 3
medical and health sciences (3) 3
medicin och hälsovetenskap (3) 3
neoplasm staging (3) 3
open-label (3) 3
organoplatinum compounds - administration & dosage (3) 3
outcomes (3) 3
patients (3) 3
qlq-c30 (3) 3
retrospective studies (3) 3
surveys and questionnaires (3) 3
time factors (3) 3
trastuzumab (3) 3
abridged index medicus (2) 2
adenocarcinoma - pathology (2) 2
adjuvant treatment (2) 2
advanced breast-cancer (2) 2
advanced gastric-cancer (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
brain neoplasms - mortality (2) 2
brain neoplasms - psychology (2) 2
brain neoplasms - therapy (2) 2
cancer research (2) 2
cancer therapies (2) 2
cell lung-cancer (2) 2
cell lung-carcinoma (2) 2
cetuximab (2) 2
chemotherapy, adjuvant - methods (2) 2
cisplatin (2) 2
clinical trials (2) 2
clinical-trials (2) 2
colon-cancer (2) 2
colorectal neoplasms - drug therapy (2) 2
colorectal neoplasms - surgery (2) 2
colorectal-cancer (2) 2
drug administration schedule (2) 2
erbb-2 protein (2) 2
gastro-esophageal junction cancer (2) 2
gastrointestinal tract (2) 2
health aspects (2) 2
her2 (2) 2
identification (2) 2
impact (2) 2
leucovorin (2) 2
liver cancer (2) 2
liver neoplasms - therapy (2) 2
medicine & public health (2) 2
neoplasms - therapy (2) 2
original reports (2) 2
perioperative chemotherapy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Oncology, ISSN 0732-183X, 12/2010, Volume 28, Issue 35, pp. 5210 - 5218
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 24, pp. 2516 - 2527
A current standard treatment for locally advanced prostate cancer is external-beam radiotherapy combined with 3 years of androgen suppression. Adverse events,... 
PHASE-III TRIAL | DEPRIVATION THERAPY | IRRADIATION | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | EORTC | RANDOMIZED-TRIAL | QUALITY-OF-LIFE | RADIOTHERAPY | RADIATION-THERAPY | ADJUVANT | Anilides - therapeutic use | Prostatic Neoplasms - radiotherapy | Follow-Up Studies | Anilides - adverse effects | Humans | Middle Aged | Male | Gonadotropin-Releasing Hormone - analogs & derivatives | Flutamide - adverse effects | Treatment Failure | Aged, 80 and over | Adult | Flutamide - therapeutic use | Prostatic Neoplasms - drug therapy | Drug Administration Schedule | Proportional Hazards Models | Combined Modality Therapy | Prostatic Neoplasms - mortality | Disease-Free Survival | Tosyl Compounds - adverse effects | Heart Diseases - mortality | Tosyl Compounds - therapeutic use | Quality of Life | Radiotherapy, Conformal - adverse effects | Aged | Androgen Antagonists - administration & dosage | Androgen Antagonists - adverse effects | Nitriles - adverse effects | Nitriles - therapeutic use | Heart attacks | Medical treatment | Mortality | Radiation therapy | Prostate cancer | Cancer therapies | Quality of life | Index Medicus | Abridged Index Medicus | Androgen Antagonists | Anilides | Life Sciences | Prostatic Neoplasms | Flutamide | Heart Diseases | Radiotherapy, Conformal | Gonadotropin-Releasing Hormone | Nitriles | Tosyl Compounds | Cancer
Journal Article
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2018, Volume 36, Issue 15, pp. 3558 - 3558
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2017, Volume 35, Issue 15_suppl, pp. e13066 - e13066
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 01/2015, Volume 33, Issue 3, pp. 80 - 80
Conference Proceeding
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 01/2015, Volume 33, Issue 3, pp. 575 - 575
Conference Proceeding
The New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 24, p. 2516
The study aims to compare the efficacy of radiotherapy along with long-term suppression of androgen against radio therapy with short-term androgen suppression... 
Usage | Care and treatment | Radiotherapy | Health aspects | Prostate cancer
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 06/2009, Volume 360, Issue 24, pp. 2516 - 2527
BACKGROUND The combination of radiotherapy plus long-term medical suppression of androgens (>= 2 years) improves overall survival in patients with locally... 
Journal Article
Annals of Oncology, ISSN 0923-7534, 06/2012, Volume 23, Issue suppl_4, pp. iv5 - iv18
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.